File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.archoralbio.2007.05.009
- Scopus: eid_2-s2.0-34848847811
- PMID: 17640614
- WOS: WOS:000250858500001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A new approach to control condylar growth by regulating angiogenesis
Title | A new approach to control condylar growth by regulating angiogenesis |
---|---|
Authors | |
Keywords | Angiogenesis Angiostatin Condylar growth Craniofacial growth deformities Endostatin FGF rAAV Stem cells VEGF |
Issue Date | 2007 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/archoralbio |
Citation | Archives Of Oral Biology, 2007, v. 52 n. 11, p. 1009-1017 How to Cite? |
Abstract | Objective: To provide a comprehensive review of the mechanisms of growth of mandibular condyle, the roles of angiogenesis enhancers and inhibitors during endochondral ossification in mandibular condyle and newly developed delivery methods for local gene delivery that may represent strategies to regulate condylar growth. Design: Narrative review. Results: Angiogenesis is the crucial step in mandibular condylar growth for it regulates the transformation from cartilage to bone. Angiognesis enhancers, especially VEGF and FGF, play important roles in the process of new blood lumen formation and invasion. On the other hand, angiostatin and endostatin inhibit angiogenesis by targeting endothelial cells and several signal cascades. Delivery methods such as liposomes, stem cells and virus vectors have been studied. Recombinant AAV-mediated gene therapy is considered as one of the most promising strategies of condylar growth management. Conclusion: AAV-mediated gene therapy using VEGF or angiogenesis inhibitor will be a promising way to regulate condylar growth at an early stage. © 2007 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/67031 |
ISSN | 2023 Impact Factor: 2.2 2023 SCImago Journal Rankings: 0.562 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, QF | en_HK |
dc.contributor.author | Rabie, ABM | en_HK |
dc.date.accessioned | 2010-09-06T05:51:23Z | - |
dc.date.available | 2010-09-06T05:51:23Z | - |
dc.date.issued | 2007 | en_HK |
dc.identifier.citation | Archives Of Oral Biology, 2007, v. 52 n. 11, p. 1009-1017 | en_HK |
dc.identifier.issn | 0003-9969 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/67031 | - |
dc.description.abstract | Objective: To provide a comprehensive review of the mechanisms of growth of mandibular condyle, the roles of angiogenesis enhancers and inhibitors during endochondral ossification in mandibular condyle and newly developed delivery methods for local gene delivery that may represent strategies to regulate condylar growth. Design: Narrative review. Results: Angiogenesis is the crucial step in mandibular condylar growth for it regulates the transformation from cartilage to bone. Angiognesis enhancers, especially VEGF and FGF, play important roles in the process of new blood lumen formation and invasion. On the other hand, angiostatin and endostatin inhibit angiogenesis by targeting endothelial cells and several signal cascades. Delivery methods such as liposomes, stem cells and virus vectors have been studied. Recombinant AAV-mediated gene therapy is considered as one of the most promising strategies of condylar growth management. Conclusion: AAV-mediated gene therapy using VEGF or angiogenesis inhibitor will be a promising way to regulate condylar growth at an early stage. © 2007 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/archoralbio | en_HK |
dc.relation.ispartof | Archives of Oral Biology | en_HK |
dc.subject | Angiogenesis | en_HK |
dc.subject | Angiostatin | en_HK |
dc.subject | Condylar growth | en_HK |
dc.subject | Craniofacial growth deformities | en_HK |
dc.subject | Endostatin | en_HK |
dc.subject | FGF | en_HK |
dc.subject | rAAV | en_HK |
dc.subject | Stem cells | en_HK |
dc.subject | VEGF | en_HK |
dc.subject.mesh | Angiogenesis Inhibitors - genetics | en_HK |
dc.subject.mesh | Animals | en_HK |
dc.subject.mesh | Cartilage - growth & development | en_HK |
dc.subject.mesh | Dependovirus - genetics | en_HK |
dc.subject.mesh | Gene Therapy - methods | en_HK |
dc.subject.mesh | Genetic Vectors - administration & dosage | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Intercellular Signaling Peptides and Proteins - genetics | en_HK |
dc.subject.mesh | Mandibular Condyle - abnormalities - blood supply - growth & development | en_HK |
dc.subject.mesh | Nanotechnology | en_HK |
dc.subject.mesh | Neovascularization, Physiologic | en_HK |
dc.subject.mesh | Stem Cell Transplantation | en_HK |
dc.title | A new approach to control condylar growth by regulating angiogenesis | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0003-9969&volume=52&spage=1009&epage=1017&date=2007&atitle=A+new+approach+to+control+condylar+growth+by+regulating+angiogenesis | en_HK |
dc.identifier.email | Rabie, ABM: rabie@hku.hk | en_HK |
dc.identifier.authority | Rabie, ABM=rp00029 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.archoralbio.2007.05.009 | en_HK |
dc.identifier.pmid | 17640614 | - |
dc.identifier.scopus | eid_2-s2.0-34848847811 | en_HK |
dc.identifier.hkuros | 143936 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-34848847811&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 52 | en_HK |
dc.identifier.issue | 11 | en_HK |
dc.identifier.spage | 1009 | en_HK |
dc.identifier.epage | 1017 | en_HK |
dc.identifier.isi | WOS:000250858500001 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Li, QF=22135394000 | en_HK |
dc.identifier.scopusauthorid | Rabie, ABM=7007172734 | en_HK |
dc.identifier.issnl | 0003-9969 | - |